This makes it easier to avoid snacking or overeating
Current Research and Future Directions While the potential for GLP-1 receptor agonists in addiction treatment is exciting, more research is needed to fully understand their long-term effects and effectiveness in humans
Data from the surpass trial series revealed that tirzepatide reduces the risk of major adverse cardiovascular events and improves blood pressure, lipid profiles, and inflammatory markers (60, 61)
Other state regulated markets Table 2 shows the status of coverage of Wegovy for obesity in four state-regulated health insurance markets: Medicaid, state-employee plans, the small group market, and the individual market
Dietary Adjustments: Eating smaller, more frequent meals and avoiding high-fat/fried foods
Healthcare Cost and Insurance Coverage The high cost of GLP-1 drugs poses a major limitation, especially in healthcare systems with restricted reimbursement policies